abemaciclib
eli lilly
['monarche,(-monarcher)', 'monarche']
not at #asco23 presents efficacy and safety by age in #monarche: efficacy was consistent in all agr groups; pts&gt;65 yrs old had more dose reductions and discontinuations older pts need to be monitored more frequently for dose adjustment 
MD, Medical Oncologist🇮🇹•Research Fellow at @JulesBordet Institute in Brussels🇧🇪 Great interest in #BreastCancer and #ImmunoOncology